Ingenol Mebutate Gel 0.06%
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Ingenol Mebutate Gel 0.06%, covering 2018-12-07 to 2018-12-07. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of Ingenol Mebutate Gel 0.06% When Applied Once Daily for 2, 3 or 4 Consecutive Days to a Treatment Area of Approximately 250 cm2 on Trunk and Extremities in Subjects With Actinic Keratosis [Phase 2]